0001562180-21-002171.txt : 20210311
0001562180-21-002171.hdr.sgml : 20210311
20210311144853
ACCESSION NUMBER: 0001562180-21-002171
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210309
FILED AS OF DATE: 20210311
DATE AS OF CHANGE: 20210311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hill, Mitch C.
CENTRAL INDEX KEY: 0001644989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 21732927
MAIL ADDRESS:
STREET 1: 1009 TENNYSON DRIVE
CITY: SOUTHLAKE
STATE: TX
ZIP: 76902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-03-09
false
0001531048
Inari Medical, Inc.
NARI
0001644989
Hill, Mitch C.
C/O INARI MEDICAL, INC.
9 PARKER, SUITE 100
IRVINE
CA
92618
false
true
false
false
Chief Financial Officer
Common Stock
2021-03-09
4
M
false
5000.00
0.457
A
73190.00
D
Common Stock
2021-03-09
4
S
false
100.00
94.05
D
73090.00
D
Common Stock
2021-03-09
4
S
false
400.00
95.5275
D
72690.00
D
Common Stock
2021-03-09
4
S
false
1500.00
97.444
D
71190.00
D
Common Stock
2021-03-09
4
S
false
2058.00
98.3925
D
69132.00
D
Common Stock
2021-03-09
4
S
false
942.00
99.2801
D
68190.00
D
Common Stock
1600.00
I
By Spouse
Stock Options (Right to buy)
0.457
2021-03-09
4
M
false
5000.00
0.00
D
2029-04-30
Common Stock
5000.00
311977.00
D
Includes 347 shares acquired under the Employee Stock Purchase Plan.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020
This transaction was executed in multiple trades at prices ranging from $95.25 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $96.90 to $97.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $97.91 to $98.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $98.93 to $99.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Option vested with respect to 25% of the underlying shares on April 30, 2020 and vests with respect to the remaining shares in 36 equal monthly installment thereafter.
/s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
2021-03-11